StayWell adds SMART on FHIR app to Krames CareEngage™ solution, increasing integration capabilities across care systems
SMART on FHIR integration now available for testing with Krames CareEngage for patient education and care management
Yardley, PA (February 21, 2017) – The StayWell Company announced today that Krames CareEngage™ powered by Doctella now features a SMART on FHIR application. The SMART on FHIR application is available for testing with clients who use CareEngage for patient education and care management. StayWell will demonstrate the CareEngage solution during #HiMSS17 at booth 3443.
CareEngage is an interactive platform that addresses real-world health needs, such as patient compliance and chronic conditions, by keeping patients better informed and engaged in their care. The platform is licensed by hospitals and health systems and can be integrated into EHR systems to improve patient safety, quality and compliance. SMART (Substitutable Medical Applications and Reusable Technologies) on FHIR (Fast Health Interoperability Resources) is a fast-growing and much-lauded technology that facilitates the connection of EHRs across health care provider organizations and allows patient education to be prescribed from, and tracked in the EHR.
Effectively engaging patients and caregivers is essential to hospitals and health systems in new value-based payment models, because engagement — which can be fostered by interactive education, communications and positive feedback — can contribute to improved patient compliance and clinical outcomes under MACRA and MIPS.
Earlier this month, early adopters of CareEngage met to discuss implementation strategies and use of the platform within their hospital business units and outlined targeted departments, processes and workflows that could be improved by CareEngage. These early adopters are part of the Krames CareEngage Collaborative, which will also assist in tracking metrics to measure platform usage and satisfaction.
“Health care regulations are putting an increased focus on patient-centered and value-based care. Giving patients anytime-access to their health information and fostering communication between health care providers, patients and their families, encourages people to take a more active role in their care. In the long run, this will lead to better health and a more satisfying care journey for patients, and improved quality, safety and reimbursement for hospitals,” said Nicole Latimer, president, StayWell.
CareEngage augments verbal instructions and print materials with state-of-the-art, customizable and interactive, multimedia tools that can be easily shared with family and caregivers.
It is a unique application of quality improvement science and physician-developed Smartlists delivered in an open, interactive content framework that maps the complete patient journey, including: patient preferences, education, care instructions, symptom tracking, beliefs, belonging, insights and patient reported outcomes and measures. The addition of SMART on FHIR to the CareEngage solution will make the integration and use of the platform across provider locations efficient for both clinicians and patients.
“SMART on FHIR is emerging as the new industry standard for patient-facing health technology solutions. It neutralizes potential issues related to platform compatibility across health systems and creates a user-friendly, seamless environment for patients and health care professionals,” said Amer Haider, CEO of Doctella. “The potential that this delivers to health systems across the country who use CareEngage is significant and timely to the pressing needs of our health care marketplace.”
Existing StayWell customers can easily integrate CareEngage into their EHR workflow using the SMART on FHIR application.
To learn more about CareEngage or to join the Krames CareEngage Collaborative, a cohort of early adopters established by StayWell, visit www.staywell.com/doctella.
Follow and participate in the conversation on Twitter: #StayWellCareEngage #MedicalErrors #PatientSafety #PatientEngagement #Checklists #DoctellaChecklists #DigitalHealth #HealthApp #SMARTonFHIR #HIMSS17
StayWell is a health solutions company that uses the science of behavior change to help people live happier, healthier lives. StayWell brings decades of experience working across the health care industry to design solutions for improving individual and organizational health outcomes, managing the health of targeted populations, and creating brand engagement for employers and health care organizations. StayWell programs have received numerous top industry honors, including the C. Everett Koop National Health Award and the Web Health Award for health engagement programs. StayWell also has received URAC and NCQA accreditation for several of its programs. StayWell is majority-owned by Healthcare Services & Solutions, LLC, a wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (“Merck”). The company is headquartered in Yardley, Pennsylvania, and also has major locations in Salt Lake City, Utah, and St. Paul, Minn. To learn more, visit http://www.staywell.com.
For over a century, Merck has been a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. For more information, visit www.merck.com and connect with us on Twitter, Facebook, YouTube and LinkedIn.
Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA
This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
Doctella.com, by Patient Doctor Technologies, Inc. and creators of Doctella Smartlist technology, is based in Silicon Valley. The company provides a comprehensive patient-centered outcomes management platform to improve the culture, communication, and engagement between patients, families, and providers. The Doctella Smartlist app was developed by leading researchers from Johns Hopkins and at other leading institutions. The StayWell Company, LLC, is an investor in Doctella. Start your journey to better, safer care at http://www.doctella.com.
Barbara Tabor, APR / 651-230-9192 / barbara@taborPR.com